发明名称 |
MODIFIED AMYLOID BETA PEPTIDE |
摘要 |
An object of the invention is to provide a peptide based on a sequence of an amyloid ² peptide that may allow for induction of enhanced immune response and is safe and efficacious for prophylaxis and treatment of Alzheimer disease. An amyloid ² peptide or a portion thereof with addition or insertion of cysteine or a cysteine analogue, and a method for enhancing immune response to amyloid ² using said peptide, a medicament for prophylaxis and treatment of Alzheimer disease using said amyloid peptide that induces an enhanced immune response, amd a DNA vaccine comprising a gene coding for an amyloid ² peptide or a sequence derived from an amyloid ² peptide with addition or insertion of cysteine or a cysteine analogue, as expected to be similarly efficacious. |
申请公布号 |
KR20110071117(A) |
申请公布日期 |
2011.06.28 |
申请号 |
KR20117010876 |
申请日期 |
2009.10.16 |
申请人 |
THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE |
发明人 |
MATSUDA JUNICHI;KAMINAKA KAZUYOSHI;NOZAKI CHIKATERU |
分类号 |
C07K14/435;A61K38/17;A61P25/28;C12N15/12 |
主分类号 |
C07K14/435 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|